Surgeons implant first medically suspended heart pump in US
Editor's Note
Cardiothoracic surgeons at Emory University Hospital have conducted the first US implantation of the BrioVAD System, a new ventricular assist device (VAD) from BrioHealth Solutions, Cardiovascular Business News reported November 25.
According to the article, the BrioVAD System features a magnetically suspended, hemocompatible pump designed to minimize adverse events and improve patient safety and quality of life. Already used in hundreds of patients internationally, the device is new to the US.
The implantation by Emory surgeons marks the launch of the INNOVATE clinical trial, a non-inferiority study comparing the safety and effectiveness of the BrioVAD System to existing therapies for end-stage heart failure. Other participating institutions include Cleveland Clinic, Duke University, and the University of Chicago. All will focus on both short- and long-term outcomes, following patients for a full two years after treatment.
Free Daily News
- Study: Non-operative management of pediatric appendicitis cost-effective compared to surgery
- AMA letter expresses opposition to CRNA use of “nurse anesthesiologist” title
- House report criticizes COVID-19 pandemic response, calls for reform
- Medical device coating could reduce blood clot risks
- FDA pilot program aims to expedite high-risk medical device recall communication
- Surgeons implant first medically suspended heart pump in US
- Study: COVID-19's impact on oncological surgery offers lessons for future crises
- Study links pandemic stress to persistent increases in nursing-sensitive quality indicators
- Save the date for the 2025 OR Business Management Conference
- Study: Education, exercise improve knee OA with or without prior surgery